Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul-Aug;56(1):68-73.
doi: 10.1016/j.pcad.2013.04.002. Epub 2013 May 15.

Pathophysiology of thoracic aortic aneurysm (TAA): is it not one uniform aorta? Role of embryologic origin

Affiliations
Review

Pathophysiology of thoracic aortic aneurysm (TAA): is it not one uniform aorta? Role of embryologic origin

Jean Marie Ruddy et al. Prog Cardiovasc Dis. 2013 Jul-Aug.

Abstract

Thoracic aortic aneurysm (TAA) is a clinically silent and potentially fatal disease whose pathophysiology is poorly understood. Application of data derived from animal models and human tissue analysis of abdominal aortic aneurysms may prove misleading given current evidence of structural and biochemical aortic heterogeneity above and below the diaphragm. Genetic predisposition is more common in TAA and includes multi-faceted syndromes such as Marfan, Loeys-Dietz, and type IV Ehlers-Danlos as well as autosomal-dominant familial patterns of inheritance. Investigation into the consequences of these known mutations has provided insight into the cell signaling cascades leading to degenerative remodeling of the aortic medial extracellular matrix (ECM) with TGF-β playing a major role. Targeted research into modifying the upstream regulation or downstream effects of the TGF-β1 pathway may provide opportunities for intervention to attenuate TAA progression.

Keywords: AAA; AT1; AngII; ECM; ERK; Extracellular matrix remodeling; MMP; Matrix metalloproteinases; TAA; TGF-β; TGF-βR1 & 2; Thoracic Aortic Aneurysm; Transforming growth factor-beta; VSMC; abdominal aortic aneurysm; angiotensin II; angiotensin receptor 1; extracellular matrix; extracellular signal-regulated kinase; matrix metalloproteinase; t-PA; thoracic aortic aneurysm; tissue plasminogen activator; transforming growth factor beta; transforming growth factor beta receptor 1 & 2; vascular smooth muscle cell.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Centralized role of TGF-β1 in TAA formation. Upregulated TGF-β1 signaling in the aortic medial VSMCs may be initiated through ineffective sequestration by mutated fibrillin-1, by binding to dysfunctional receptors, or through downstream activity of AngII binding to its AT1 receptor. The generation of ROS and activation of p38MAPK can augment TGF-β1 activity. VSMC synthetic productivity is modulated by miRNA 29 and may produce MMP-2, MMP-9, and collagen. When MMPs are activated by t-PA, ECM remodeling with aneurysmal dilation ensues. Dysfunctional type III collagen and disorganization of VSMCs may further compromise the integrity of the aortic media and allow TAA formation.

References

    1. National Center for Injury Prevention and Control WISQARS Leading Causes of Death Reports, 1999-2006. available at http://webappa.cdc.gov/sasweb/ncipc/leadcaus10.html.
    1. Coady MA, Rizzo JA, Elefteriades JA. Developing surgical intervention criteria for thoracic aortic aneurysms. Card Clin. 1999;17:827–39. - PubMed
    1. Ruddy JM, Jones JA, Spinale FG, Ikonomidis JS. Regional heterogeneity within the aorta: relevance to aneurysm disease. J Thorac Cardiovasc Surg. 2008;136:1123–30. - PMC - PubMed
    1. Castellano JM, Kovacic JC, Sanz J, Fuster V. Are we ignoring the dilated thoracic aorta? Ann N Y Acad Sci. 2012;1254:164–74. - PubMed
    1. Wolinsky H. Comparison of medial growth of human thoracic and abdominal aortas. Circ Res. 1970;27:531–8. - PubMed

Publication types

MeSH terms

Substances